Carbamazepine-induced	carbamazepine-induced	O	O	O	O
cardiac	cardiac	O	DISEASE	OTHERS	I
dysfunction	dysfunction	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Characterization	characterization	O	O	O	O
of	of	O	O	O	O
two	two	O	O	O	O
distinct	distinct	O	O	O	O
clinical	clinical	O	O	O	O
syndromes	syndromes	O	O	O	O
.	.	O	O	O	O

A	a	O	O	O	O
patient	patient	O	O	O	O
with	with	O	O	O	O
sinus	sinus	O	DISEASE	OTHERS	I
bradycardia	bradycardia	O	DISEASE	OTHERS	I
and	and	O	O	O	O
atrioventricular	atrioventricular	O	DISEASE	OTHERS	I
block	block	O	DISEASE	OTHERS	I
,	,	O	O	O	O
induced	induced	O	O	O	O
by	by	O	O	O	O
carbamazepine	carbamazepine	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
prompted	prompted	O	O	O	O
an	an	O	O	O	O
extensive	extensive	O	O	O	O
literature	literature	O	O	O	O
review	review	O	O	O	O
of	of	O	O	O	O
all	all	O	O	O	O
previously	previously	O	O	O	O
reported	reported	O	O	O	O
cases	cases	O	O	O	O
.	.	O	O	O	O

From	from	O	O	O	O
the	the	O	O	O	O
analysis	analysis	O	O	O	O
of	of	O	O	O	O
these	these	O	O	O	O
cases	cases	O	O	O	O
,	,	O	O	O	O
two	two	O	O	O	O
distinct	distinct	O	O	O	O
forms	forms	O	O	O	O
of	of	O	O	O	O
carbamazepine-associated	carbamazepine-associated	O	O	O	O
cardiac	cardiac	O	DISEASE	OTHERS	I
dysfunction	dysfunction	O	DISEASE	OTHERS	I
emerged	emerged	O	O	O	O
.	.	O	O	O	O

One	one	O	O	O	O
patient	patient	O	O	O	O
group	group	O	O	O	O
developed	developed	O	O	O	O
sinus	sinus	O	O	OTHERS	I
tachycardias	tachycardias	O	O	OTHERS	I
in	in	O	O	O	O
the	the	O	O	O	O
setting	setting	O	O	O	O
of	of	O	O	O	O
a	a	O	O	O	O
massive	massive	O	O	O	O
carbamazepine	carbamazepine	CHEMICALS	O	OTHERS	I
overdose	overdose	O	DISEASE	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
second	second	O	O	O	O
group	group	O	O	O	O
consisted	consisted	O	O	O	O
almost	almost	O	O	O	O
exclusively	exclusively	O	O	O	O
of	of	O	O	O	O
elderly	elderly	O	O	O	O
women	women	O	O	O	O
who	who	O	O	O	O
developed	developed	O	O	O	O
potentially	potentially	O	O	O	O
life-threatening	life-threatening	O	O	O	O
bradyarrhythmias	bradyarrhythmias	O	O	OTHERS	I
or	or	O	O	O	O
atrioventricular	atrioventricular	O	O	OTHERS	I
conduction	conduction	O	O	OTHERS	I
delay	delay	O	O	OTHERS	I
,	,	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
either	either	O	O	O	O
therapeutic	therapeutic	O	O	O	O
or	or	O	O	O	O
modestly	modestly	O	O	O	O
elevated	elevated	O	O	O	O
carbamazepine	carbamazepine	CHEMICALS	O	OTHERS	I
serum	serum	O	O	O	O
levels	levels	O	O	O	O
.	.	O	O	O	O

Because	because	O	O	O	O
carbamazepine	carbamazepine	CHEMICALS	O	OTHERS	I
is	is	O	O	O	O
widely	widely	O	O	O	O
used	used	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
treatment	treatment	O	O	O	O
of	of	O	O	O	O
many	many	O	O	O	O
neurologic	neurologic	O	O	O	O
and	and	O	O	O	O
psychiatric	psychiatric	O	DISEASE	OTHERS	I
conditions	conditions	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
recognition	recognition	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
latter	latter	O	O	O	O
syndrome	syndrome	O	O	O	O
has	has	O	O	O	O
important	important	O	O	O	O
implications	implications	O	O	O	O
for	for	O	O	O	O
the	the	O	O	O	O
use	use	O	O	O	O
of	of	O	O	O	O
this	this	O	O	O	O
drug	drug	O	O	O	O
in	in	O	O	O	O
elderly	elderly	O	O	O	O
patients	patients	O	O	O	O
.	.	O	O	O	O

